Journal of the Society for Gynecologic Investigation

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

http://mc.manuscriptcentral.com/rsci

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dechend, R.
Right arrow Articles by Luft, F. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dechend, R.
Right arrow Articles by Homuth, V.
Right arrow Articles by Wallukat, G.
Right arrow Articles by Müller, D. N.
Right arrow Articles by Krause, M.
Right arrow Articles by Dudenhausen, J.
Right arrow Articles by Haller, H.
Right arrow Articles by Luft, F. C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Journal of the Society for Gynecologic Investigation, Vol. 13, No. 2, 79-86 (2006)
DOI: 10.1016/j.jsgi.2005.11.006


Reviews

Agonistic Antibodies Directed at the Angiotensin II, AT1 Receptor in Preeclampsia

Ralf Dechend, MD

Medical Faculty of the Charité, Franz Volhard Clinic HELIOS Klinikum-Berlin, Berlin; Department of Obstetrics, Charité Campus Virchow, Berlin; Max Delbrück Center for Molecular Medicine, Berlin-Buch, Berlin; Department of Nephrology, Medical School of Hannover, Hannover, Germany; Helios-Clinic, Charité, Campus-Buch, Priv.Doz., Berlin, Germany dechand{at}fvk-berlin.de

Volker Homuth, MD

Gerd Wallukat, PhD

Dominik N. Müller, PhD

Manja Krause, MD

Joachim Dudenhausen, MD

Hermann Haller, MD

Friedrich C. Luft, MD

Medical Faculty of the Charité, Franz Volhard Clinic HELIOS Klinikum-Berlin, Berlin; Department of Obstetrics, Charité Campus Virchow, Berlin; Max Delbrück Center for Molecular Medicine, Berlin-Buch, Berlin; Department of Nephrology, Medical School of Hannover, Hannover, Germany

Immune mechanisms and circulating mediators may be important in the pathogenesis of preeclampsia. We review our findings on agonistic antibodies against the angiotensin II (Aug II) receptor (AT1-AA) and their possible role in the pathogenesis of this disorder. AT1-AA appear in the course of preeclampsia and are largely gone by 6 weeks after delivery. AT1-AA detection relies on a bioassay using spontaneously beating neonatal rat cardiomyocytes. Their specificity has been documented by other methods, including Western blotting, co-localization, and co-immunoprecipitation experiments. AT1-AA induce signaling in vascular cells and trophoblasts including transcription factor activation. The signaling results in tissue factor production and reactive oxygen species generation, both of which have been implicated in preeclampsia. The role of AT1-AA in preeclampsia and other severe hypertensive conditions has not yet been proved with certainty. However, we believe the findings are compelling and warrant further study.

Key Words: Preeclampsia • angiotensin • agonistic autoantibodies • tissue factor • reactive oxygen species


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?